Xenetic Biosciences Inc expected to post a loss of 72 cents a share - Earnings Preview

Xenetic Biosciences

05/05/2025 22:16

Xenetic Biosciences Inc XBIO.OQ XBIO.O is expected to show a rise in quarterly revenue when it reports  results on May 7 (estimated) for the period ending March 31 2025

The Framingham Massachusetts-based  company is expected to report a 31.2% increase in revenue to $670 thousand from $510.82 thousand a year ago, according to the estimate from one analyst, based on LSEG data.

​LSEG's mean analyst estimate for Xenetic Biosciences Inc is for a loss of 72 cents per share.

The one available analyst rating on the shares is "hold".

The mean earnings estimate of analysts was unchanged in the last three months. ​

This summary was machine generated May 5 at 21:16 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)